Phase 3 Results of Brepocitinib for the Treatment of Dermatomyositis by Madaline Spencer| Published on: Apr 21, 2026

Phase 3 Results of Brepocitinib for the Treatment of Dermatomyositis by Madaline Spencer| Published on: Apr 21, 2026 Ben Zimmer, CEO of Priovant Therapeutics, discusses results from the recent phase 3 study testing brepocitinib for the treatment of dermatomyositis (DM). https://checkrare.com/phase-3-results-of-brepocitinib-for-the-treatment-of-dermatomyositis/